{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:14:29Z","timestamp":1789809269209,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1684\/bdc.2010.1049","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T15:58:33Z","timestamp":1565711913000},"page":"559-569","source":"Crossref","is-referenced-by-count":8,"title":["Toxicit\u00e9 h\u00e9patique de la chimioth\u00e9rapie du cancer colorectal m\u00e9tastatique : revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"97","author":[{"given":"I.","family":"Baumgaertner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Vaillant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hannoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Poynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2010.1049_bib0005","series-title":"2000: cancer incidence, mortality and prevalence worldwide","year":"2001"},{"key":"10.1684\/bdc.2010.1049_bib0010","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"key":"10.1684\/bdc.2010.1049_bib0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","article-title":"Trends in long-term survival following liver resection for hepatic colorectal metastases","volume":"235","author":"Choti","year":"2002","journal-title":"Ann Surg"},{"key":"10.1684\/bdc.2010.1049_bib0020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.sla.0000138076.72547.b1","article-title":"Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)","volume":"240","author":"Fernandez","year":"2004","journal-title":"Ann Surg"},{"key":"10.1684\/bdc.2010.1049_bib0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.sla.0000160703.75808.7d","article-title":"Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases","volume":"241","author":"Pawlik","year":"2005","journal-title":"Ann Surg"},{"key":"10.1684\/bdc.2010.1049_bib0030","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(94)92529-1","article-title":"Factors influencing the natural history of colorectal liver metastases","volume":"343","author":"Stangl","year":"1994","journal-title":"Lancet"},{"key":"10.1684\/bdc.2010.1049_bib0035","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/bjs.1800771115","article-title":"Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history","volume":"77","author":"Scheele","year":"1990","journal-title":"Br J Surg"},{"key":"10.1684\/bdc.2010.1049_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1684\/bdc.2010.1049_bib0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1148\/radiology.174.3.2406776","article-title":"Surgical decision making for large bowel cancer metastatic to the liver","volume":"174","author":"Sugarbaker","year":"1990","journal-title":"Radiology"},{"key":"10.1684\/bdc.2010.1049_bib0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.1800800302","article-title":"Hepatectomy for liver metastases","volume":"80","author":"Scheele","year":"1993","journal-title":"Br J Surg"},{"key":"10.1684\/bdc.2010.1049_bib0055","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.1684\/bdc.2010.1049_bib0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"Folfiri followed by Folfox-6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2010.1049_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory al","volume":"351","author":"Cunningham","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2010.1049_bib0080","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2010.1049_bib0085","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1200\/JCO.2008.20.8397","article-title":"Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer","volume":"27","author":"Bokemeyer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0090","unstructured":"Folprecht, abstract ASCO 2009 CELIM study abstract 296."},{"key":"10.1684\/bdc.2010.1049_bib0095","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1200\/JCO.2006.08.1620","article-title":"Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer","volume":"25","author":"Van Cutsem","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0100","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2010.1049_bib0105","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2008.16.7759","article-title":"Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil\/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials","volume":"26","author":"Arkenau","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0110","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with Folfox-4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"10.1684\/bdc.2010.1049_bib0115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1684\/bdc.2010.1049_bib0120","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/bjc.1998.333","article-title":"Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer","volume":"77","author":"Peppercorn","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2010.1049_bib0125","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1200\/JCO.1993.11.12.2386","article-title":"Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy","volume":"11","author":"Moertel","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0130","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.acra.2005.02.010","article-title":"Effects of oral 5-fluorouracil drugs on hepatic fat content in patients with colon cancer","volume":"12","author":"Miyake","year":"2005","journal-title":"Acad Radiol"},{"key":"10.1684\/bdc.2010.1049_bib0135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1091-255X(98)80025-5","article-title":"Hepatic steatosis as a potential risk factor for major hepatic resection","volume":"2","author":"Behrns","year":"1998","journal-title":"J Gastrointest Surg"},{"key":"10.1684\/bdc.2010.1049_bib0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1072-7515(00)00261-1","article-title":"Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection","volume":"191","author":"Belghiti","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1684\/bdc.2010.1049_bib0145","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/bjs.5820","article-title":"Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis","volume":"94","author":"Gomez","year":"2007","journal-title":"Br J Surg"},{"key":"10.1684\/bdc.2010.1049_bib0150","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.gassur.2003.08.005","article-title":"Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy","volume":"7","author":"Parikh","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1684\/bdc.2010.1049_bib0155","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.gassur.2003.09.012","article-title":"Impact of steatosis on perioperative outcome following hepatic resection","volume":"7","author":"Kooby","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1684\/bdc.2010.1049_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.1684\/bdc.2010.1049_bib0165","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0170","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0175","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.1840200528","article-title":"Liver injury following normothermic ischemia in steatotic rat liver","volume":"20","author":"Hui","year":"1994","journal-title":"Hepatology"},{"key":"10.1684\/bdc.2010.1049_bib0180","article-title":"[Nonalcoholic steatohepatitis]","volume":"66","author":"Ratziu","year":"2005","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1684\/bdc.2010.1049_bib0185","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1684\/bdc.2010.1049_bib0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jamcollsurg.2005.01.024","article-title":"Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases","volume":"200","author":"Fernandez","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1684\/bdc.2010.1049_bib0195","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ejso.2008.01.001","article-title":"Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases","volume":"34","author":"Kandutsch","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"10.1684\/bdc.2010.1049_bib0205","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1200\/jco.2009.27.15_suppl.4097","volume":"27","author":"Wicherts","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0210","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0215","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2004.99.106","volume":"22","author":"Tisman","year":"2004","journal-title":"J clin oncol"},{"key":"10.1684\/bdc.2010.1049_bib0220","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0399-8320(06)73542-4","volume":"11","author":"Arot\u00e7arena","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1684\/bdc.2010.1049_bib0225","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1053\/j.seminoncol.2006.08.001","article-title":"Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events","volume":"33","author":"Hurwitz","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0230","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer"},{"key":"10.1684\/bdc.2010.1049_bib0235","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2008.12.013","article-title":"Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant Xelox\/Folfox therapy of colorectal cancer liver metastases","volume":"35","author":"Klinger","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0240","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jamcollsurg.2007.06.290","article-title":"Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases","volume":"206","author":"Reddy","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1684\/bdc.2010.1049_bib0245","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1200\/JCO.2008.17.7857","article-title":"Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases","volume":"26","author":"Kesmodel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1245\/s10434-006-9074-0","article-title":"Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study","volume":"14","author":"D\u2019Angelica","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0255","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2007.13.7679","article-title":"Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer","volume":"26","author":"Gruenberger","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0260","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2009.27.15_suppl.4093","article-title":"Postoperative liver function recovery after hepatic resection for colorectal metastases previously treated with bevacizumab","volume":"27","author":"Adam","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0265","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1752-1947-2-227","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in a patient receiving bevacizumab for metastatic colorectal cancer: a case report","volume":"2","author":"Agarwal","year":"2009","journal-title":"J Med Case Reports"},{"key":"10.1684\/bdc.2010.1049_bib0270","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/0008-5472.948.65.3","article-title":"Controlling tumor growth by modulating endogenous production of reactive oxygen species","volume":"65","author":"Laurent","year":"2005","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2010.1049_bib0275","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0168-8278(00)00055-6","article-title":"Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats","volume":"34","author":"Shimizu","year":"2001","journal-title":"J Hepatol"},{"key":"10.1684\/bdc.2010.1049_bib0280","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/002215540104900112","article-title":"Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats","volume":"49","author":"Taniguchi","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"10.1684\/bdc.2010.1049_bib0285","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1079562","article-title":"Angiogenesis-independent endothelial protection of liver: role of VEGF-R1","volume":"299","author":"LeCouter","year":"2003","journal-title":"Science"},{"key":"10.1684\/bdc.2010.1049_bib0290","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/sj.bmt.1703061","article-title":"Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation","volume":"27","author":"Iguchi","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1684\/bdc.2010.1049_bib0295","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition","volume":"125","author":"Deleve","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1684\/bdc.2010.1049_bib0300","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1200\/JCO.2007.11.6566","article-title":"Effect of molecular therapeutics on liver regeneration in a murine model","volume":"26","author":"Van Buren","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ctrv.2004.04.002","article-title":"Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview","volume":"30","author":"Barber","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1684\/bdc.2010.1049_bib0310","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1200\/JCO.2007.12.1764","article-title":"Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?","volume":"25","author":"Mocellin","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0315","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1200\/JCO.2005.07.100","article-title":"Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer","volume":"23","author":"Kemeny","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0320","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2214\/ajr.146.4.717","article-title":"Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation","volume":"146","author":"Shea","year":"1986","journal-title":"AJR Am J Roentgenol"},{"key":"10.1684\/bdc.2010.1049_bib0325","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/1097-0142(19860815)58:4<855::AID-CNCR2820580409>3.0.CO;2-6","article-title":"Liver pathology following hepatic arterial infusion chemotherapy. Hepatic toxicity with FUDR","volume":"58","author":"Doria","year":"1986","journal-title":"Cancer"},{"key":"10.1684\/bdc.2010.1049_bib0330","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","article-title":"A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases","volume":"206","author":"Chang","year":"1987","journal-title":"Ann Surg"},{"key":"10.1684\/bdc.2010.1049_bib0335","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","article-title":"A randomized trial of continuous intravenous versus hepatic intra-arterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial","volume":"7","author":"Hohn","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0340","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1245\/s10434-008-9882-5","article-title":"Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases","volume":"15","author":"Pulitano","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0345","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.surg.2005.09.023","article-title":"Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases","volume":"139","author":"Tanaka","year":"2006","journal-title":"Surgery"},{"key":"10.1684\/bdc.2010.1049_bib0350","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jso.21042","article-title":"Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases","volume":"97","author":"White","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0355","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2006.05.8727","article-title":"Complete response of colorectal liver metastases after chemotherapy: does it mean cure?","volume":"24","author":"Benoist","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2010.1049_bib0360","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/sj.bjc.6603670","article-title":"Safe liver resection following chemotherapy for colorectal metastases is a matter of timing","volume":"96","author":"Welsh","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2010.1049_bib0365","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/annonc\/mdn540","article-title":"Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery","volume":"19","author":"Cacheux","year":"2008","journal-title":"Ann oncol"},{"key":"10.1684\/bdc.2010.1049_bib0370","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/01.sla.0000145964.08365.01","article-title":"Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115308493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115308493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T12:14:46Z","timestamp":1664108086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115308493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0007455115308493"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2010.1049","relation":{"is-cited-by":[{"id-type":"doi","id":"10.4240\/wjgs.v5.i5.146","asserted-by":"object"}]},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}